BCX 4430 3022 CHR-2797 is converted into a

CHR-2797 is converted into a pharmacologically active acid product (CHR-79888) inside cells

which as client proteins depend on functional HsP90 for maintenance

IWP-4 also causes a significant down regulation of SPARC and COL1A1

PDGFRβ and Kit (c-Kit)

59(1):289-98

BCX 4430 3022 CHR-2797 is converted into aGalidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,